Article
Pharmacokinetics of riluzole: evidence for glucuronidation as a major metabolic pathway not associated with UGT1A1 genotype.
Biopharmaceutics & drug disposition - 1 Apr 2008
van Kan H J M, van den Berg L H, Groeneveld G J, van der Straaten R J H M, van Vught P W J, Lie-A-Huen L, Guchelaar H-J
Abstract excerpt
Pharmacokinetic studies of riluzole show a large inter-individual variability of the drug's clearance and serum concentrations. Optimizing the individual dosage of riluzole may have the potential to improve the effect of riluzole treatment on survival of patients with amyotrophic lateral sclerosi...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
